Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.57 |
| ▸ | NPC1 | O15118 | 1/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.57 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.57 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.57 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.57 |
| ▸ | RAB9A | P51151 | 1/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.57 |
| ▸ | MAOB | P27338 | 9/20 | 0.56 |
| ▸ | MAOA | P21397 | 8/20 | 0.56 |
| ▸ | AR | P10275 | 3/20 | 0.54 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.45 |
| ▸ | CYP19A1 | P11511 | 4/20 | 0.44 |
| ▸ | MGLL | Q99685 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23335180 | 0.95 | KDM4E (0.53) | KDM4ENPC1ALDH1A1CYP1A2CYP2C9 | |
| SCHEMBL5694453 | 0.94 | KDM4E (0.56) | KDM4ENPC1ALDH1A1CYP1A2CYP2C9 | |
| SCHEMBL2984524 | 0.93 | KDM4E (0.54) | KDM4ENPC1ALDH1A1CYP1A2CYP2C9 | |
| SCHEMBL7846740 | 0.93 | KDM4E (0.54) | KDM4ENPC1ALDH1A1CYP1A2CYP2C9 | |
| SCHEMBL7835337 | 0.93 | KDM4E (0.54) | KDM4ENPC1ALDH1A1CYP1A2CYP2C9 | |
| SCHEMBL8386311 | 0.93 | KDM4E (0.54) | KDM4ENPC1ALDH1A1CYP1A2CYP2C9 | |
| SCHEMBL2979985 | 0.93 | KDM4E (0.54) | KDM4ENPC1ALDH1A1CYP1A2CYP2C9 | |
| SCHEMBL1017349 | 0.88 | MAOB (0.59) | KDM4ENPC1ALDH1A1CYP1A2CYP2C9 | |
| SCHEMBL9097861 | 0.88 | TSHR (0.59) | KDM4ENPC1ALDH1A1CYP1A2CYP2C9 | |
| SCHEMBL17608773 | 0.85 | KDM4E (0.49) | KDM4ENPC1ALDH1A1CYP1A2CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1551878-B | 17 beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases | SCHERING CORP | 2011-08-10 | — | — | CN | disclosed |
| CN-1551878-A | 17 beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases | ���鹫˾ | 2004-12-01 | — | — | CN | disclosed |
| US-20030187106-A1 | Red, organge color; photostability, heat resistance | MORETTI ROBERT (CH) | 2003-10-02 | — | — | US | disclosed |
| US-6603020-B1 | Exhibiting a red or orange fluorescence | CIBA SPECIALTY CHEMICALS CORPORATION | 2003-08-05 | — | — | US | disclosed |
| EP-1087005-A1 | Fluorescent diketopyrrolopyrroles | Ciba SC Holding AG (CH) | 2001-03-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030187106-A1 | Red, organge color; photostability, heat resistance | CBR1, CBR3, DPP8 | KDM4E 2949/4885NPC1 1614/4885ALDH1A1 63/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.